AKT Regulates Mitotic Progression of Mammalian Cells by Phosphorylating MASTL, Leading to Protein Phosphatase 2A

Irfana Reshi1, Misbah Un Nisa2, Umer Farooq1

  • 1Department of Biotechnology, University of Kashmir, Srinagar, India.

Insights

AKT phosphorylates MASTL at T299, enhancing its activity and promoting mitosis. This AKT-MASTL axis boosts cancer cell proliferation, offering new therapeutic targets for colorectal cancer.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Microtubule-associated serine/threonine kinase like (MASTL), or Greatwall (Gwl) kinase, regulates mitosis by inhibiting protein phosphatase 2A (PP2A) and activating cyclin-dependent kinase 1 (CDK1).
  • MASTL is implicated in various cancers and tumor recurrence, with its activation mechanism incompletely understood.
  • CDK1-mediated phosphorylation is known to activate MASTL, but other contributing factors remain elusive.

Purpose of the Study:

  • To elucidate the complete mechanism of MASTL activation during mitosis.
  • To investigate the role of AKT in MASTL activation and its downstream effects on mitotic progression.
  • To determine the interplay between AKT, MASTL, and cancer cell proliferation.

Main Methods:

  • Phosphorylation site mapping of MASTL.
  • In vitro kinase assays to assess AKT and CDK1 activity on MASTL.
  • Cellular assays in colorectal cancer lines to evaluate MASTL inhibition/silencing effects on AKT-mediated proliferation.
  • Western blotting and immunofluorescence to detect protein phosphorylation and localization.

Main Results:

  • AKT phosphorylates MASTL at threonine residue 299 (T299), a critical site for MASTL activation.
  • AKT enhances CDK1-mediated phosphorylation of MASTL, leading to increased MASTL activity.
  • Activated MASTL promotes mitotic progression via PP2A inhibition.
  • MASTL activation by AKT potentiates the oncogenic potential of AKT, driving proliferation in colorectal cancer cells.
  • Inhibition or silencing of MASTL attenuates AKT-driven proliferation in colorectal cancer cell lines.

Conclusions:

  • AKT plays a significant role in mammalian cell mitosis through the phosphorylation and activation of MASTL.
  • The AKT-MASTL signaling pathway is crucial for mitotic progression and contributes to cancer cell proliferation.
  • Targeting the AKT-MASTL axis presents a potential therapeutic strategy for cancers where this pathway is dysregulated.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K